Extracellular vesicle encapsulated Homer1a as novel nanotherapeutics against intracerebral hemorrhage in a mouse model

期刊论文
出版模式：

开放获取
发表日期：

2024年4月6日

查看全文

Xiaowei Fei,
Li Wang,
Ya-nan Dou,
Fei Fei,
Yanyu Zhang,
Weihao Lv,
Xin He,
Xiuquan Wu,
Wangshu Chao,
Hongqing Chen,
Jialiang Wei,
Dakuan Gao,
Zhou Fei

摘要

Homer1a and A2 astrocytes are involved in the regulation of inflammation induced by intracerebral hemorrhage (ICH). However, there is no anticipated treatment strategy based on the anti-inflammatory effect of Homer1a and A2 astrocytes. Here, we successfully induced A2 astrocytes in vitro, and then we report an efficient method to prepare Homer1a⁺ EVs derived from A2 astrocytes which making it more stable, safe, and targetable to injured neurons. Homer1a⁺ EVs promotes the conversion of A1 to A2 astrocytes in ICH mice. Homer1a⁺ EVs inhibits activation and nuclear translocation of NF-κB, thereby regulating transcription of IL-17A in neurons. Homer1a⁺ EVs inhibits the RAGE/NF-κB/IL-17 signaling pathway and the binding ability of IL-17A: IL17-AR and RAGE: DIAPH1. In addition, Homer1a⁺ EVs ameliorates the pathology, behavior, and survival rate in GFAP^CreHomer1^fl/−Homer1a^± and Nestin^CreRAGE^fl/fl ICH mice. Our study provides a novel insight and potential for the clinical translation of Homer1a⁺ EVs in the treatment of ICH.